Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Distribution of vaccines which require refrigerated or frozen storage can be challenging and expensive. The adenovirus vector platform has been widely used for COVID-19 vaccines while several further candidate vaccines using the platform are in clinical development. In current liquid formulations, a...
Autores principales: | Zhang, C, Berg, A, Joe, C, Dalby, PA, Douglas, A |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
Springer Nature
2023
|
Ejemplares similares
-
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
por: Cheng Zhang, et al.
Publicado: (2023-06-01) -
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Adam Berg, et al.
Publicado: (2021-10-01) -
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
por: Charlotte Davis, et al.
Publicado: (2024-06-01) -
Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
por: Hermosilla, E, et al.
Publicado: (2022) -
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Folegatti, P, et al.
Publicado: (2019)